Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting, 46627-46628 [E8-18393]
Download as PDF
<![CDATA[
rmajette on PRODPC74 with NOTICES
Federal Register / Vol. 73, No. 155 / Monday, August 11, 2008 / Notices
guidelines which have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule,
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special
Exposure Cohort.
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2009.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose (c) upon
request by the Secretary, HHS, advising
the Secretary on whether there is a class
of employees at any Department of
Energy facility who were exposed to
radiation but for whom it is not feasible
to estimate their radiation dose, and on
whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class.
Matters To Be Discussed: The agenda
for the Advisory Board meeting
includes: NIOSH Program Status
Update; Special Exposure Cohort (SEC)
Petitions for: Pantex; Connecticut
Aircraft Nuclear Engine Laboratory
(CANEL); SEC Petition Updates:
Chapman Valve; Special Exposure
Cohort (SEC) Petition Status Update(s);
Department of Labor (DOL) Update;
Department of Energy (DOE) Update;
Work Group reports; Subcommittee on
Dose Reconstruction Reviews Report;
and Board Future Plans and Schedules.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted according the policy
provided below. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), if a
person making a comment gives his or
her name, no attempt will be made to
redact that name. NIOSH will take
VerDate Aug<31>2005
15:22 Aug 08, 2008
Jkt 214001
reasonable steps to ensure that
individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting
posted on a public Web site. Such
reasonable steps include: (a) A
statement read at the start of each public
comment period stating that transcripts
will be posted and names of speakers
will not be redacted; (b) A printed copy
of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comment; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
notice that announces Board and
Subcommittee meetings. If an
individual in making a statement
reveals personal information (e.g.,
medical information) about themselves
that information will not usually be
redacted. The NIOSH Freedom of
Information Act coordinator will,
however, review such revelations in
accordance with the Freedom of
Information Act and the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information. All disclosures of
information concerning third parties
will be redacted. If it comes to the
attention of the Designated Federal
Officer (DFO) that an individual wishes
to share information with the Board but
objects to doing so in a public forum,
the DFO will work with that individual,
in accordance with the Federal
Advisory Committee Act, to find a way
that the Board can hear such comments.
Contact Person for More Information:
Zaida Burgos, Committee Management
Specialist, NIOSH, CDC, 1600 Clifton
Road, Atlanta, Georgia 30033,
Telephone (404) 498–2548 Toll Free:
(800) CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: August 4, 2008.
Daniel Riedford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E8–18426 Filed 8–8–08; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
46627
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Service
Administration
Advisory Committee on
Interdisciplinary, Community-Based
Linkages; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on
Interdisciplinary, Community-Based
Linkages (ACICBL).
Dates and Times: September 10, 2008,
11 a.m.–4 p.m., EST., September 11, 2008,
11 a.m.–4 p.m., EST.
Place: (Web Conference).
Status: The meeting will be open to the
public; Web conference access limited only
by availability of telephone ports.
Purpose: The Committee will be focusing
on rural issues and how the Title VII
Interdisciplinary, Community-Based Training
Grant Programs identified under sections
751–756, Part D of the Public Health Service
Act can respond to the current rural
healthcare workforce needs. The Committee
has invited speakers to highlight various
topics related to rural healthcare workforce
issues including, but not limited to,
discipline specific shortages; recruitment and
retention; health professions training; faculty
development; telemedicine; and other
specific rural health care issues. The meeting
will afford committee members with the
opportunity to identify and discuss the
current status of the healthcare workforce in
rural America and formulate appropriate
recommendations to the Secretary and to the
Congress regarding a variety of training
strategies to address the health workforce
shortage issues.
Agenda: The ACICBL agenda includes an
overview of the Committee’s general business
activities, presentations by experts on rural
healthcare workforce related issues, and
discussion sessions specific for the
development of recommendations to be
addressed in the Eighth Annual ACICBL
Report.
Agenda items are subject to change as
dictated by the priorities of the Committee.
Supplementary Information: The ACICBL
will meet on Wednesday, September 10 and
Thursday, September 11, 2008 from 11 a.m.
to 4 p.m. (EST) via Intercall LiveMeeting Web
conference. To join online, click the link
below. Once connected call the number
below and use the same conference ID to be
connected to the call. If you have not joined
an Intercall LiveMeeting Web conference
before, please log in 20 minutes before the
meeting as you may need to install an
Intercall reader to access the Web conference.
Meeting Link: https://
psa.on.raindance.com/confmgr/
public_unsched.jsp?confId=7829159.
Meeting Phone #: (888) 272–7337.
Conference ID: 7829159.
Meeting Subject: HRSA Advisory
Committee on Interdisciplinary, CommunityBased Linkages (ACICBL).
E:\FR\FM\11AUN1.SGM
11AUN1
46628
Federal Register / Vol. 73, No. 155 / Monday, August 11, 2008 / Notices
Moderator: Ashley Golden
Moderator E-mail: a_golden@teampsa.com.
For Further Information Contact: Anyone
requesting information regarding the
Committee should contact Louis D.
Coccodrilli, Designated Federal Official for
the ACICBL, Bureau of Health Professions,
Health Resources and Services
Administration, Parklawn Building, Rm. 9–
36, 5600 Fishers Lane, Rockville, Maryland
20857; (301) 443–6950 or
lcoccodrilli@hrsa.gov. Marie Ulysse, HRSA
Scholar, can also be contacted for inquiries
at (301) 443–6529 or mulysse@hrsa.gov.
Dated: August 4, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E8–18393 Filed 8–8–08; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
rmajette on PRODPC74 with NOTICES
Submission for OMB Review;
Comment Request; The Prevalence
and Incidence of HIV Molecular
Variants and Their Correlation With
Risk Behaviors and HIV Treatment in
Brazilian Blood Donors
Summary: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Heart, Lung, and Blood Institute
(NHLBI), the National Institutes of
Health (NIH) has submitted to the Office
of Management and Budget (OMB) a
request to review and approve the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on May 29, 2008, pages 30951–
30952 and allowed 60 days for public
comment. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institutes of
Health may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a current valid
OMB control number.
Proposed Collection: Title: The
Prevalence and Incidence of HIV
Molecular Variants and Their
Correlation With Risk Behaviors and
HIV Treatment in Brazilian Blood
Donors. Type of Information Collection
Request: New. Need and Use of
VerDate Aug<31>2005
15:22 Aug 08, 2008
Jkt 214001
Information Collection: Establishing and
monitoring viral prevalence and
incidence rates, and identifying risk
behaviors for HIV incidence among
blood donors, are critical to assessing
and reducing risk of HIV transmission
through blood transfusion. Identifying
donation samples from donors with
recent HIV infection is particularly
critical as it enables characterization of
the viral subtypes currently transmitted
within the screened population and
hence most likely to ‘‘break-through’’
routine screening measures (i.e., periseroconversion window period
donations). Molecular surveillance of
incident HIV infections in blood donors
not only characterizes genotypes of
recently infected donors for purposes of
blood safety, but also enables
documentation of the rates of primary
transmission of anti-viral drug resistant
strains in the community, serving a
public health role in identifying new
HIV infections for anti-retroviral
treatment. Both a prospective
surveillance and a case-control design
are proposed to enroll all eligible HIV
seropositives detected at three blood
˜
centers in Brazil (Sao Paulo, Belo
´
Horizante, and Recıfe) plus a satellite
center in Rio de Janeiro. A comparison
of epidemiological risk profiles will be
made between the seropositive donors
and a group of randomly selected
seronegative donors.
There are three study aims.
Laboratory studies (LS–EIA testing and
sequencing of pol region) on linked
specimens from all enrolled HIV cases,
will allow for estimation of HIV
prevalence and incidence relative to
genotype and putative route of
infection. Data derived from molecular
genotyping, including drug resistant
genotypes, will be provided, along with
counseling, to all enrolled HIV positive
donors to facilitate their clinical care via
referral to the Brazilian national HIV
treatment system. Our findings will be
compared to trends in prevalence,
incidence and molecular variants from
studies of the general population and
high risk populations in Brazil, thus
allowing for broad monitoring of the
HIV epidemic in Brazil and assessment
of the impact of donor selection criteria
on these parameters. Finally, HIV cases
and a group of controls, through
responses to a questionnaire, will
provide data on HIV risk behaviors
among prospective blood donors. This
HIV risk behavior data will be used as
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
covariates in the molecular surveillance
analyses described above, as well as aid
in assessing whether modifications may
be needed to Brazil’s routine blood
center operational donor screening
questionnaire.
The study participants will return to
their local blood center for the
administration of an informed consent
form, explaining the confidential nature
of the research study as well as the risks
and benefits to their participation. Once
enrolled, they will be asked to complete
the self-administered risk factor
questionnaire. In addition, a small blood
sample will be collected from each HIV
seropositive participant to be used for
the genotyping and drug resistance
testing. The results of the drug
resistance testing will be communicated
back to the seropositive participants
during an in-person counseling session
at the blood center.
Defining prevalence and incidence in
blood donors and residual risk of HIV
transmission by transfusions may lead
to new regulations and blood safety
initiatives in Brazil. The data can be
used to project the yield, safety impact
and cost effectiveness of implementing
enhanced testing strategies such as
combination antigen-antibody assays
and/or NAT. Determination of HIV risk
factors in donors (first time versus
repeat donor status; volunteer versus
replacement status; demographics and
risk behaviors) will support policy
discussions over strategies to recruit the
safest possible donors in Brazil. The
findings from this project will also
complement similar monitoring of HIV
prevalence, incidence, transfusion risk
and molecular variants in the U.S. and
other funded international REDS–II
sites, thus allowing direct comparisons
of these parameters on a global level.
Frequency of Response: Once.
Affected Public: Individuals. Type of
Respondents: Adult Blood Donors. The
annual reporting burden is as follows:
Estimated Number of Respondents:
2,000; Estimated Number of Responses
per Respondent: 1; Average Burden of
Hours per Response: 0.40 (including
administration of the informed consent
form and questionnaire completion
instructions); and Estimated Total
Annual Burden Hours Requested: 800.
The annualized cost to respondents is
estimated at: $5,200 (based on $6.50 per
hour). There are no Capital Costs to
report. There are no Operating or
Maintenance Costs to report.
E:\FR\FM\11AUN1.SGM
11AUN1
]]>Agencies
[Federal Register Volume 73, Number 155 (Monday, August 11, 2008)]
[Notices]
[Pages 46627-46628]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18393]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Service Administration
Advisory Committee on Interdisciplinary, Community-Based
Linkages; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Committee on Interdisciplinary, Community-Based
Linkages (ACICBL).
Dates and Times: September 10, 2008, 11 a.m.-4 p.m., EST.,
September 11, 2008, 11 a.m.-4 p.m., EST.
Place: (Web Conference).
Status: The meeting will be open to the public; Web conference
access limited only by availability of telephone ports.
Purpose: The Committee will be focusing on rural issues and how
the Title VII Interdisciplinary, Community-Based Training Grant
Programs identified under sections 751-756, Part D of the Public
Health Service Act can respond to the current rural healthcare
workforce needs. The Committee has invited speakers to highlight
various topics related to rural healthcare workforce issues
including, but not limited to, discipline specific shortages;
recruitment and retention; health professions training; faculty
development; telemedicine; and other specific rural health care
issues. The meeting will afford committee members with the
opportunity to identify and discuss the current status of the
healthcare workforce in rural America and formulate appropriate
recommendations to the Secretary and to the Congress regarding a
variety of training strategies to address the health workforce
shortage issues.
Agenda: The ACICBL agenda includes an overview of the
Committee's general business activities, presentations by experts on
rural healthcare workforce related issues, and discussion sessions
specific for the development of recommendations to be addressed in
the Eighth Annual ACICBL Report.
Agenda items are subject to change as dictated by the priorities
of the Committee.
Supplementary Information: The ACICBL will meet on Wednesday,
September 10 and Thursday, September 11, 2008 from 11 a.m. to 4 p.m.
(EST) via Intercall LiveMeeting Web conference. To join online,
click the link below. Once connected call the number below and use
the same conference ID to be connected to the call. If you have not
joined an Intercall LiveMeeting Web conference before, please log in
20 minutes before the meeting as you may need to install an
Intercall reader to access the Web conference.
Meeting Link: https://psa.on.raindance.com/confmgr/public_
unsched.jsp?confId=7829159.
Meeting Phone #: (888) 272-7337.
Conference ID: 7829159.
Meeting Subject: HRSA Advisory Committee on Interdisciplinary,
Community-Based Linkages (ACICBL).
[[Page 46628]]
Moderator: Ashley Golden
Moderator E-mail: a_golden@team-psa.com.
For Further Information Contact: Anyone requesting information
regarding the Committee should contact Louis D. Coccodrilli,
Designated Federal Official for the ACICBL, Bureau of Health
Professions, Health Resources and Services Administration, Parklawn
Building, Rm. 9-36, 5600 Fishers Lane, Rockville, Maryland 20857;
(301) 443-6950 or lcoccodrilli@hrsa.gov. Marie Ulysse, HRSA Scholar,
can also be contacted for inquiries at (301) 443-6529 or
mulysse@hrsa.gov.
Dated: August 4, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E8-18393 Filed 8-8-08; 8:45 am]
BILLING CODE 4165-15-P
